loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Dr. Reddy's Laboratories said commercial supplies of its semaglutide product will be delayed

ICICIdirect Research 10 Jul 2026 DISCLAIMER

News: Dr. Reddy's Laboratories said commercial supplies of its semaglutide product will be delayed for a certain period after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API). The company said there is no impact on patient safety for products already supplied and that it is investigating the root cause while implementing corrective measures to ensure product quality

View: As per our calculations, the possible dent in the revenues could be Rs 2800-3000 crore, which is ~6-7% of the estimated FY27. The impact on EBITDA is also likely to be similar. We keep tab on the development

Impact: Negative

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere